Skip to main content
NCBI home page
Sarcoma logoLink to Sarcoma
. 2000 Mar;4(1-2):37–45. doi: 10.1155/S1357714X00000074

Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells

Jie Cai 1, Tong Zheng 1, Rizwan Masood 2, D Lynne Smith 1, David R Hinton 2, Caryn Nae Kim 3, Guofu Fang 3, Kapil Bhalla 3, Parkash S Gill 1,✉
PMCID: PMC2408359  PMID: 18521433

Abstract

Paclitaxel is a microtubule stabilizing drug that causes dividing cells to arrest and then undergo apoptosis. It also has antiangiogenic activity because it alters cytoskeletal structure, affecting migration and invasion. Paclitaxel is an effective treatment for AIDS-related Kaposi’s sarcoma (KS). KS is a tumor in which there is marked proliferation of endothelial cells in addition to the tumor cells, which themselves share many markers with activated (proliferating) endothelial cells.We sought to determine the mechanism by which paclitaxel exerts its anti-KS tumor effects. In vitro, KS cells are very sensitive to paclitaxel, with half-maximal growth inhibition observed at 0.8 nM. Inhibition of migration of KS cells was also observed at nanomolar concentrations of the drug. Paclitaxel induced cell cycle arrest with an accumulation of cells in sub-G1.This was accompanied in vitro by various events typical of apoptosis: phosphorylation of two anti-apoptotic proteins Bcl-2 and Bcl-xL , release of cytochrome c into the cytoplasm, cleavage and activation of caspase-3. In vitro results were borne out by studies of KS tumor xenografts in nude mice. Paclitaxel (10 mg/kg) inhibited tumor growth by 75% over 21 days. Histological examination of the tumors revealed a decrease in proliferative index, a decrease in the number of mitotic figures and an increase in apoptotic cells compared to tumors from untreated mice.

Full Text

The Full Text of this article is available as a PDF (293.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belotti D., Vergani V., Drudis T., Borsotti P., Pitelli M. R., Viale G., Giavazzi R., Taraboletti G. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res. 1996 Nov;2(11):1843–1849. [PubMed] [Google Scholar]
  2. Bhalla K., Ibrado A. M., Tourkina E., Tang C., Mahoney M. E., Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia. 1993 Apr;7(4):563–568. [PubMed] [Google Scholar]
  3. Burt H. M., Jackson J. K., Bains S. K., Liggins R. T., Oktaba A. M., Arsenault A. L., Hunter W. L. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). Cancer Lett. 1995 Jan 6;88(1):73–79. doi: 10.1016/0304-3835(94)03614-o. [DOI] [PubMed] [Google Scholar]
  4. Chatlynne L. G., Ablashi D. V. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol. 1999 Jun;9(3):175–185. doi: 10.1006/scbi.1998.0089. [DOI] [PubMed] [Google Scholar]
  5. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13(8):795–808. doi: 10.1002/cyto.990130802. [DOI] [PubMed] [Google Scholar]
  6. Ensoli B., Markham P., Kao V., Barillari G., Fiorelli V., Gendelman R., Raffeld M., Zon G., Gallo R. C. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest. 1994 Nov;94(5):1736–1746. doi: 10.1172/JCI117521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiorelli V., Gendelman R., Samaniego F., Markham P. D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest. 1995 Apr;95(4):1723–1734. doi: 10.1172/JCI117849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fiorelli V., Gendelman R., Sirianni M. C., Chang H. K., Colombini S., Markham P. D., Monini P., Sonnabend J., Pintus A., Gallo R. C. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 1998 Feb 1;91(3):956–967. [PubMed] [Google Scholar]
  9. Gagandeep S., Novikoff P. M., Ott M., Gupta S. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett. 1999 Feb 8;136(1):109–118. doi: 10.1016/s0304-3835(98)00388-7. [DOI] [PubMed] [Google Scholar]
  10. Gill P. S., Tsai Y. C., Rao A. P., Spruck C. H., 3rd, Zheng T., Harrington W. A., Jr, Cheung T., Nathwani B., Jones P. A. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8257–8261. doi: 10.1073/pnas.95.14.8257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gill P. S., Tulpule A., Espina B. M., Cabriales S., Bresnahan J., Ilaw M., Louie S., Gustafson N. F., Brown M. A., Orcutt C. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun;17(6):1876–1883. doi: 10.1200/JCO.1999.17.6.1876. [DOI] [PubMed] [Google Scholar]
  12. Gross A., Jockel J., Wei M. C., Korsmeyer S. J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998 Jul 15;17(14):3878–3885. doi: 10.1093/emboj/17.14.3878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harvey K. J., Blomquist J. F., Ucker D. S. Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities. Mol Cell Biol. 1998 May;18(5):2912–2922. doi: 10.1128/mcb.18.5.2912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ibrado A. M., Huang Y., Fang G., Bhalla K. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Differ. 1996 Aug;7(8):1087–1094. [PubMed] [Google Scholar]
  15. Ibrado A. M., Liu L., Bhalla K. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res. 1997 Mar 15;57(6):1109–1115. [PubMed] [Google Scholar]
  16. Jordan M. A., Wendell K., Gardiner S., Derry W. B., Copp H., Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996 Feb 15;56(4):816–825. [PubMed] [Google Scholar]
  17. Jürgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4997–5002. doi: 10.1073/pnas.95.9.4997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klauber N., Parangi S., Flynn E., Hamel E., D'Amato R. J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 1997 Jan 1;57(1):81–86. [PubMed] [Google Scholar]
  19. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997 Jun;3(6):614–620. doi: 10.1038/nm0697-614. [DOI] [PubMed] [Google Scholar]
  20. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997 Nov 14;91(4):479–489. doi: 10.1016/s0092-8674(00)80434-1. [DOI] [PubMed] [Google Scholar]
  21. Lunardi-Iskandar Y., Gill P., Lam V. H., Zeman R. A., Michaels F., Mann D. L., Reitz M. S., Jr, Kaplan M., Berneman Z. N., Carter D. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst. 1995 Jul 5;87(13):974–981. doi: 10.1093/jnci/87.13.974. [DOI] [PubMed] [Google Scholar]
  22. Lunardi-Iskandar Y., Gill P., Lam V. H., Zeman R. A., Michaels F., Mann D. L., Reitz M. S., Jr, Kaplan M., Berneman Z. N., Carter D. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst. 1995 Jul 5;87(13):974–981. doi: 10.1093/jnci/87.13.974. [DOI] [PubMed] [Google Scholar]
  23. Martin S. J., Green D. R. Protease activation during apoptosis: death by a thousand cuts? Cell. 1995 Aug 11;82(3):349–352. doi: 10.1016/0092-8674(95)90422-0. [DOI] [PubMed] [Google Scholar]
  24. Masood R., Cai J., Zheng T., Smith D. L., Naidu Y., Gill P. S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):979–984. doi: 10.1073/pnas.94.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McGuire W. P., Rowinsky E. K., Rosenshein N. B., Grumbine F. C., Ettinger D. S., Armstrong D. K., Donehower R. C. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989 Aug 15;111(4):273–279. doi: 10.7326/0003-4819-111-4-273. [DOI] [PubMed] [Google Scholar]
  26. Mullins D. W., Burger C. J., Elgert K. D. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol. 1999 Jun 1;162(11):6811–6818. [PubMed] [Google Scholar]
  27. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993 Aug 27;74(4):609–619. doi: 10.1016/0092-8674(93)90509-o. [DOI] [PubMed] [Google Scholar]
  28. Rabkin C. S., Janz S., Lash A., Coleman A. E., Musaba E., Liotta L., Biggar R. J., Zhuang Z. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med. 1997 Apr 3;336(14):988–993. doi: 10.1056/NEJM199704033361403. [DOI] [PubMed] [Google Scholar]
  29. Ray S., Ponnathpur V., Huang Y., Tang C., Mahoney M. E., Ibrado A. M., Bullock G., Bhalla K. 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother Pharmacol. 1994;34(5):365–371. doi: 10.1007/BF00685559. [DOI] [PubMed] [Google Scholar]
  30. Reed J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol. 1995 Nov;7(6):541–546. doi: 10.1097/00001622-199511000-00012. [DOI] [PubMed] [Google Scholar]
  31. Roth W., Wagenknecht B., Grimmel C., Dichgans J., Weller M. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br J Cancer. 1998;77(3):404–411. doi: 10.1038/bjc.1998.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rowinsky E. K., Cazenave L. A., Donehower R. C. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 1990 Aug 1;82(15):1247–1259. doi: 10.1093/jnci/82.15.1247. [DOI] [PubMed] [Google Scholar]
  33. Saville M. W., Lietzau J., Pluda J. M., Feuerstein I., Odom J., Wilson W. H., Humphrey R. W., Feigal E., Steinberg S. M., Broder S. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet. 1995 Jul 1;346(8966):26–28. doi: 10.1016/s0140-6736(95)92654-2. [DOI] [PubMed] [Google Scholar]
  34. Siegal B., Levinton-Kriss S., Schiffer A., Sayar J., Engelberg I., Vonsover A., Ramon Y., Rubinstein E. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer. 1990 Feb 1;65(3):492–498. doi: 10.1002/1097-0142(19900201)65:3<492::aid-cncr2820650320>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  35. Tortora G., di Isernia G., Sandomenico C., Bianco R., Pomatico G., Pepe S., Bianco A. R., Ciardiello F. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res. 1997 Nov 15;57(22):5107–5111. [PubMed] [Google Scholar]
  36. Weninger W., Partanen T. A., Breiteneder-Geleff S., Mayer C., Kowalski H., Mildner M., Pammer J., Stürzl M., Kerjaschki D., Alitalo K. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest. 1999 Feb;79(2):243–251. [PubMed] [Google Scholar]
  37. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997 Feb 21;275(5303):1129–1132. doi: 10.1126/science.275.5303.1129. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES